Use of rapamycin for inhibiting of cell death

Details for Australian Patent Application No. 2003224669 (hide)

Owner WYETH

Inventors Adelman, Steven Jay

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2003224669

PCT Number PCT/US03/07334

PCT Pub. Number WO2003/077915

Priority 60/364,188 13.03.02 US

Filing date 11 March 2003

Wipo publication date 29 September 2003

International Classifications

A61K 031/436

A61P 025/30 Drugs for disorders of the nervous system

A61P 019/02 Drugs for skeletal disorders

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/364,188 13.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-A-2003224669

9 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224670-NETWORK ACCESS RISK MANAGEMENT

2003224668-SELF-ALIGNED NANOTUBE FIELD EFFECT TRANSISTOR AND METHOD OF FABRICATING SAME